Yi Liang

机构：Nanjing Forestry University, Chinese Academy of Medical Sciences & Peking Union Medical College, Wenzhou Medical University, National Cancer Center, Wuhan Business University, Gannan Normal University, Zhongshan Hospital of Xiamen University, Women’s Health Care, Xiamen Medical College, Hubei University, Chongqing Medical University, Leibniz Institute for Neurobiology · ORCID：0000-0002-7349-8300

发表论文 173 篇 · 总被引 5134 次 · h-index 42

代表论文

• Amyloid fibril structures and ferroptosis activation induced by ALS-causing SOD1 mutations (2024 · Science Advances · 被引 22)
• Molecularly Imprinted Polymers for Highly Specific Bioorthogonal Catalysis Inside Cells (2024 · Angewandte Chemie International Edition · 被引 14)
• Phospholipid‐Drug Conjugates Self‐Organized into Well‐Defined Supramolecular Nanotubes for Efficient Drug Delivery (2025 · Angewandte Chemie International Edition · 被引 6)
• Chemocatalytic Cell Tagging Platform for Recording Cell‐Cell Interactions via Engineered Palladium‐Based Artificial Metalloenzymes (2025 · Angewandte Chemie International Edition · 被引 5)
• Distinct amyloid fibril structures formed by ALS-causing SOD1 mutants G93A and D101N (2025 · EMBO Reports · 被引 3)
• The impact of an artificial intelligence (AI)-assisted education program on mental health, social support and quality of life in older individuals with head and neck cancer: study protocol of a randomized controlled trial (2026 · BMC Geriatrics · 被引 1)